TY  - GEN
AU  - Falchook,Gerald S
AU  - Lippman,Scott M
AU  - Bastida,Christel C
AU  - Kurzrock,Razelle
TI  - Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment
SN  - 1097-0347
PY  - 2014///1108
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - metabolism
KW  - Bevacizumab
KW  - Drug Therapy, Combination
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunohistochemistry
KW  - Lapatinib
KW  - Male
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - Quinazolines
KW  - administration & dosage
KW  - Receptor, ErbB-2
KW  - Salivary Ducts
KW  - Salivary Gland Neoplasms
KW  - drug therapy
KW  - Trastuzumab
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1002/hed.23429
ER  -